[{"NetIncomeLoss_1_Q3_USD":-105735000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":51938923.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":51981468.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":46756000.0,"TreasuryStockCommonShares_0_Q3_shares":3033.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":946000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":2367000.0,"PaymentsForRestructuring_3_Q3_USD":24079000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":397165000.0,"Depreciation_3_Q3_USD":1981000.0,"Depreciation_1_Q3_USD":700000.0,"RestructuringReserveSettledWithoutCash2_3_Q3_USD":2438000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":8763000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":1347000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":32000.0,"AssetsCurrent_0_Q3_USD":698884000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":368829000.0,"RestructuringCharges_3_Q3_USD":27873000.0,"RestructuringCharges_1_Q3_USD":-529000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":143454000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":35099000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7451326.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":7451326.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":2157000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-763000.0,"MarketableSecuritiesCurrent_0_Q3_USD":484267000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":766339000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-763000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":211008000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":74078000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3_Q3_shares":550890.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":51938923.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":51981468.0,"AssetsFairValueDisclosure_0_Q3_USD":668537000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":165000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":76000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":-628000.0,"CommonStockValue_0_Q3_USD":5000.0,"Revenues_3_Q3_USD":5014000.0,"Revenues_1_Q3_USD":1639000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":7091000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-369171000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-106498000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-10913000.0,"OtherAssetsNoncurrent_0_Q3_USD":3427000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":184270000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":21069000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":2669419000.0,"Liabilities_0_Q3_USD":81047000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q3_shares":986996.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":7091000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-349000.0,"TreasuryStockCommonValue_0_Q3_USD":400000.0,"CommonStockSharesIssued_0_Q3_shares":52025862.0,"Assets_0_Q3_USD":738628000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-349000.0,"StockholdersEquity_0_Q3_USD":657581000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":345000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":483321000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":12580983.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-2012389000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":57565000.0,"AssetImpairmentCharges_3_Q3_USD":0.0,"CommonStockSharesOutstanding_0_Q3_shares":52022829.0,"InvestmentsFairValueDisclosure_0_Q3_USD":484267000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":6439000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":978000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":19863000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-346691000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":51938923.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":51981468.0,"LiabilitiesCurrent_0_Q3_USD":59665000.0,"AccountsPayableCurrent_0_Q3_USD":4289000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":30347000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":184270000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":975000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":186637000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":2144000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":7404000.0,"NetIncomeLoss_3_Q3_USD":-368822000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":313000.0,"ProfitLoss_3_Q3_USD":-368822000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-2.03,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-7.1,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-763000.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_3_Q3_shares":0.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_1_Q3_shares":0.0,"ShareBasedCompensation_3_Q3_USD":75250000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":26546000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":37.04,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":3647000.0,"CommonStockSharesAuthorized_0_Q3_shares":120000000.0,"OperatingIncomeLoss_3_Q3_USD":-377750000.0,"OperatingIncomeLoss_1_Q3_USD":-107158000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-366000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":4264646.0,"RestructuringReserve_0_Q3_USD":1356000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":738628000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":9147000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":75250000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":20108000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":13843000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":8620000.0,"OperatingExpenses_3_Q3_USD":382764000.0,"OperatingExpenses_1_Q3_USD":108797000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":-40182000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":484267000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":6045000.0,"Ticker":"SAGE","CIK":"1597553","name":"SAGE THERAPEUTICS, INC.","OfficialName":"Sage Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2034401653.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]